Fingerprint
Dive into the research topics of 'A phase 1 study of efatutazone, an oral peroxisome proliferator-activated receptor gamma agonist, administered to patients with advanced malignancies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically